These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 1917656)
21. Influence of route of vaccine administration against experimental intramammary infection caused by Escherichia coli. Tomita GM; Nickerson SC; Owens WE; Wren B J Dairy Sci; 1998 Aug; 81(8):2159-64. PubMed ID: 9749381 [TBL] [Abstract][Full Text] [Related]
22. Effects of adjuvants on safety and efficacy of an Escherichia coli J5 bacterin. Hogan JS; Cannon VB; Smith KL; Rinehart C; Miller S J Dairy Sci; 2005 Feb; 88(2):534-42. PubMed ID: 15653518 [TBL] [Abstract][Full Text] [Related]
23. Severity of E. coli mastitis is mainly determined by cow factors. Burvenich C; Van Merris V; Mehrzad J; Diez-Fraile A; Duchateau L Vet Res; 2003; 34(5):521-64. PubMed ID: 14556694 [TBL] [Abstract][Full Text] [Related]
24. Opsonic activity of serum and whey from cows immunized with the ferric citrate receptor. Wise AJ; Hogan JS; Takemura K; Smith KL J Dairy Sci; 2003 Jan; 86(1):146-51. PubMed ID: 12613859 [TBL] [Abstract][Full Text] [Related]
25. Intramammary challenge with Escherichia coli following immunization with a curli-producing Escherichia coli. Todhunter DA; Smith KL; Hogan JS; Nelson L J Dairy Sci; 1991 Mar; 74(3):819-25. PubMed ID: 2071713 [TBL] [Abstract][Full Text] [Related]
26. Temporal patterns of lost milk production following clinical mastitis in a large Michigan Holstein herd. Bartlett PC; van Wijk J; Wilson DJ; Green CD; Miller GY; Majewski GA; Heider LE J Dairy Sci; 1991 May; 74(5):1561-72. PubMed ID: 1880266 [TBL] [Abstract][Full Text] [Related]
27. Vitamin E as an adjuvant in an Escherichia coli J5 vaccine. Hogan JS; Weiss WP; Smith KL; Todhunter DA; Schoenberger PS; Williams SN J Dairy Sci; 1993 Feb; 76(2):401-7. PubMed ID: 8445093 [TBL] [Abstract][Full Text] [Related]
28. Efficacy of an Escherichia coli J5 bacterin administered to primigravid heifers. Hogan JS; Bogacz VL; Aslam M; Smith KL J Dairy Sci; 1999 May; 82(5):939-43. PubMed ID: 10342231 [TBL] [Abstract][Full Text] [Related]
29. Efficacy of vaccination with a Klebsiella pneumoniae siderophore receptor protein vaccine for reduction of Klebsiella mastitis in lactating cattle. Gorden PJ; Kleinhenz MD; Ydstie JA; Brick TA; Slinden LM; Peterson MP; Straub DE; Burkhardt DT J Dairy Sci; 2018 Nov; 101(11):10398-10408. PubMed ID: 30197148 [TBL] [Abstract][Full Text] [Related]
30. Bacterial growth, inflammatory cytokine production, and neutrophil recruitment during coliform mastitis in cows within ten days after calving, compared with cows at midlactation. Shuster DE; Lee EK; Kehrli ME Am J Vet Res; 1996 Nov; 57(11):1569-75. PubMed ID: 8915431 [TBL] [Abstract][Full Text] [Related]
32. Impact of the analytical treatment of explanatory variables on the explanatory/response relationship. Farver TB; Gonzalez RN Acta Vet Scand Suppl; 1988; 84():456-8. PubMed ID: 3068982 [No Abstract] [Full Text] [Related]
33. Immunization of dairy cows with an Escherichia coli J5 lipopolysaccharide vaccine. Tomita GM; Todhunter DA; Hogan JS; Smith KL J Dairy Sci; 1995 Oct; 78(10):2178-85. PubMed ID: 8598402 [TBL] [Abstract][Full Text] [Related]
34. Vaccination of cows with rough Escherichia coli mutants fails to protect against experimental intramammary bacterial challenge. Hill AW Vet Res Commun; 1991; 15(1):7-16. PubMed ID: 2048289 [TBL] [Abstract][Full Text] [Related]
35. Intramammary immunization with ultraviolet-killed Escherichia coli shows partial protection against late gestation intramammary challenge with a homologous strain. Pomeroy B; Gurjar A; Sipka A; Klaessig S; Salmon S; Quesnell R; Schukken YH J Dairy Sci; 2016 Nov; 99(11):9014-9026. PubMed ID: 27638260 [TBL] [Abstract][Full Text] [Related]
36. [Escherichia coli mastitis in cattle. I. Clinical diagnosis and epidemiological aspects]. Schukken YH; Kremer WD; Lohuis JA Tijdschr Diergeneeskd; 1989 Aug; 114(15-16):829-38. PubMed ID: 2678588 [TBL] [Abstract][Full Text] [Related]
37. Vaccines against bovine mastitis in the New Zealand context: what is the best way forward? Denis M; Wedlock DN; Lacy-Hulbert SJ; Hillerton JE; Buddle BM N Z Vet J; 2009 Jun; 57(3):132-40. PubMed ID: 19521461 [TBL] [Abstract][Full Text] [Related]
38. Effect of passive transfer status and vaccination with Escherichia coli (J5) on mortality in comingled dairy calves. Tyler JW; Hancock DD; Wilson L; Muller F; Krytenberg D; Bradish S J Vet Intern Med; 1999; 13(1):36-9. PubMed ID: 10052061 [TBL] [Abstract][Full Text] [Related]
39. The economic implications of bioengineered mastitis control. Miles H; Lesser W; Sears P J Dairy Sci; 1992 Feb; 75(2):596-605. PubMed ID: 1560148 [TBL] [Abstract][Full Text] [Related]
40. Effect of changes in number of doses and anatomic location for administration of an Escherichia coli bacterin on serum IgG1 and IgG2 concentrations in dairy cows. Erskine RJ; Brockett AR; Beeching ND; Hull RW; Bartlett PC Am J Vet Res; 2010 Jan; 71(1):120-4. PubMed ID: 20043791 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]